Therapeutic methods and compounds
View Patent ↗The invention provides diketopiperazines of formula I. The invention also provides pharmaceutical compositions comprising the diketopiperazines, or pharmaceutically-acceptable salts or prodrugs thereof, as the active ingredient. The invention further provides therapeutic treatments that utilize the diketopiperazines of formula I, including inhibition of a proliferative disease or condition, inhibition of angiogenesis, treatment of an angiogenic disease or condition, treatment of cancer and precancerous conditions, treatment of a fibrotic disorder, treatment of a viral infection, treatment of an Akt-mediated disease or condition, inhibition of the production, release or both of matrix metalloproteinase-9, and inhibition of Akt activation.
1. A method of reducing the severity of or reducing the incidence of a disease or condition selected from the group consisting of astrocytoma, breast cancer, glioma and melanoma comprising administering to an animal in need thereof an effective amount of a diketopiperazine or a pharmaceutically-acceptable salt or prodrug thereof, wherein the diketopiperazine is biphenyl-4-yl-(3,6-dioxo-piperazin-2-yl)-acetic acid methyl ester.
2. The method of claim 1 further comprising treating the animal with another treatment for the disease or condition.
3. The method of claim 2 wherein the other treatment is the administration of one or more other drugs suitable for treating the disease or condition.
4. A method of inhibiting angiogenesis comprising administering to an animal in need thereof an effective amount of a diketopiperazine or a pharmaceutically-acceptable salt or prodrug thereof, wherein the diketopiperazine is biphenyl-4-yl-(3,6-dioxo-piperazin-2-yl)-acetic acid methyl ester.
5. The method of claim 4 further comprising treating the animal with another treatment for the disease or condition.
6. The method of claim 5 wherein the other treatment is the administration of one or more other drugs suitable for treating the disease or condition.